{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:22:58Z","timestamp":1788538978551,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Liver fibrosis, a compensatory repair response to chronic liver injury, is caused by various pathogenic factors, and hepatic stellate cell (HSC) activation and phenotypic transformation are regarded as key events in its progression. Ferroptosis, a novel form of programmed cell death, is also closely related to different pathological processes, including those associated with liver diseases. Here, we investigated the effect of doxofylline (DOX), a xanthine derivative with potent anti-inflammatory activity, on liver fibrosis as well as the associated mechanism. Our results indicated that in mice with CCl<jats:sub>4<\/jats:sub>-induced liver fibrosis, DOX attenuated hepatocellular injury and the levels of liver fibrosis indicators, inhibited the TGF-\u03b2\/Smad signaling pathway, and significantly downregulated the expression of HSC activation markers, both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. Furthermore, inducing ferroptosis in activated HSCs was found to be critical for its anti-liver fibrosis effect. More importantly, ferroptosis inhibition using the specific inhibitor, deferoxamine (DFO) not only abolished DOX-induced ferroptosis, but also led to resistance to the anti-liver fibrosis effect of DOX in HSCs. In summary, our results showed an association between the protective effect of DOX against liver fibrosis and HSC ferroptosis. Thus, DOX may be a promising anti-hepatic fibrosis agent.<\/jats:p>","DOI":"10.3389\/fphar.2023.1135366","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:29:34Z","timestamp":1679027374000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway"],"prefix":"10.3389","volume":"14","author":[{"given":"Lenan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1139\/cjpp-2020-0049","article-title":"Hepatoprotective effect of linagliptin against liver fibrosis induced by carbon tetrachloride in mice","volume":"99","author":"Abd Elmaaboud","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cphy.c120016","article-title":"Iron homeostasis in the liver","volume":"3","author":"Anderson","year":"2013","journal-title":"Compr. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: Machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s1359-6446(04)03333-1","article-title":"Transferrin: Structure, function and potential therapeutic actions","volume":"10","author":"Gomme","year":"2005","journal-title":"Drug. Discov. Today."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/hep.27606","article-title":"Cre-ativity in the liver: Transgenic approaches to targeting hepatic nonparenchymal cells","volume":"61","author":"Greenhalgh","year":"2015","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free. Radic. Biol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/21691401.2020.1730391","article-title":"The protective effect of doxofylline against lipopolysaccharides (LPS)-induced activation of NLRP3 inflammasome is mediated by SIRT1 in human pulmonary bronchial epithelial cells","volume":"48","author":"Jiao","year":"2020","journal-title":"Artif. Cells. Nanomed. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer. Commun. (Lond)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: A translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell. death. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.2147\/copd.S150887","article-title":"Doxofylline is not just another theophylline","volume":"12","author":"Matera","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.phymed.2015.08.002","article-title":"Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells","volume":"22","author":"Ooko","year":"2015","journal-title":"Phytomedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.pupt.2010.04.002","article-title":"Doxofylline: A \"novofylline","volume":"23","author":"Page","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood. Cells. Mol. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpba.2013.02.017","article-title":"Development of a validated LC-MS\/MS method for determination of doxofylline on rat dried blood spots and urine: Application to pharmacokinetics","author":"Rao","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free. Radic. Biol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biopha.2018.06.060","article-title":"Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway","volume":"106","author":"Sui","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2015.03.039","article-title":"Mechanisms of liver fibrosis resolution","volume":"63","author":"Tacke","year":"2015","journal-title":"J. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","article-title":"Characterization of ferroptosis in murine models of hemochromatosis","volume":"66","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/iub.1348","article-title":"Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating NLRP3 inflammasome pathway","volume":"67","author":"Wu","year":"2015","journal-title":"IUBMB. Life."},{"key":"B26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/gast.2003.50012","article-title":"Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors","volume":"124","author":"Yang","year":"2003","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jmr.2549","article-title":"Identifying the antiasthmatic target of doxofylline using immobilized \u03b22 -adrenoceptor based high-performance affinity chromatography and site-directed molecular docking","volume":"29","author":"Zhang","year":"2016","journal-title":"J. Mol. Recognit."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"","journal-title":"Autophagy"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.redox.2020.101619","article-title":"The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells","volume":"36","author":"Zhang","year":"","journal-title":"Redox. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"644901","DOI":"10.3389\/fcell.2021.644901","article-title":"TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Cell. Dev. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1135366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T04:29:36Z","timestamp":1679027376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1135366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":32,"alternative-id":["10.3389\/fphar.2023.1135366"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1135366","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"article-number":"1135366"}}